Home / Companies / UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program has 0 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program" is on file.

What these totals cover: FDA records filed under the name "UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program".

Latest inspection: Sep 29, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	9	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	1	0	0	0	0
2024	1	0	0	0	0
2023	0	0	0	0	0
2022	1	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	1	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

9 inspections from Aug 12, 2009 to Sep 29, 2025.

Date	Site	Product	Classification	FEI
Sep 29, 2025	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Jan 4, 2024	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Feb 10, 2022	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Jun 19, 2019	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Jul 12, 2018	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Jul 7, 2016	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Aug 26, 2013	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Aug 5, 2011	Los Angeles, CA	Biologics	No Action Indicated (NAI)	2074237
Aug 12, 2009	Los Angeles, CA	Biologics	Voluntary Action Indicated (VAI)	2074237

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 2074237	Los Angeles, CA	9	Sep 29, 2025

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program and the FDA: common questions

Has UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program received an FDA warning letter?

No FDA warning letter addressed to the name "UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program received an FDA Form 483?

FDA has not published a Form 483 for "UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program?

The most recent FDA inspection on file ended Sep 29, 2025 at Los Angeles, CA and was classified NAI. FDA has 9 inspections of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on file.

Need more than this page shows? Ask about UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.